Your browser doesn't support javascript.
loading
Gut microbiota-stem cell niche crosstalk: A new territory for maintaining intestinal homeostasis.
Ma, Ning; Chen, Xiyue; Johnston, Lee J; Ma, Xi.
Afiliación
  • Ma N; State Key Laboratory of Animal Nutrition, College of Animal Science and Technology China Agricultural University Beijing China.
  • Chen X; State Key Laboratory of Animal Nutrition, College of Animal Science and Technology China Agricultural University Beijing China.
  • Johnston LJ; West Central Research & Outreach Center University of Minnesota Morris Minnesota USA.
  • Ma X; State Key Laboratory of Animal Nutrition, College of Animal Science and Technology China Agricultural University Beijing China.
Imeta ; 1(4): e54, 2022 Dec.
Article en En | MEDLINE | ID: mdl-38867904
ABSTRACT
Intestinal epithelium undergoes rapid cellular turnover, relying on the local niche, to support intestinal stem cells (ISCs) function and self-renewal. Research into the association between ISCs and disease continues to expand at a rapid rate. However, the detailed interaction of ISCs and gut microbes remains to be elucidated. Thus, this review witnessed major advances in the crosstalk between ISCs and gut microbes, delivering key insights into (1) construction of ISC niche and molecular mechanism of how to jointly govern epithelial homeostasis and protect against intestinal diseases with the participation of Wnt, bone morphogenetic protein, and Notch; (2) differentiation fate of ISCs affect the gut microbiota. Meanwhile, the presence of intestinal microbes also regulates ISC function; (3) microbiota regulation on ISCs by Wnt and Notch signals through pattern recognition receptors; (4) how do specific microbiota-related postbiotics influence ISCs to maintain intestinal epithelial regeneration and homeostasis that provide insights into a promising alternative therapeutic method for intestinal diseases. Considering the detailed interaction is still unclear, it is necessary to further explore the regulatory role of gut microbiota on ISCs to utilize microbes to alleviate gut disorders. Furthermore, these major advances collectively drive us ever closer to breakthroughs in regenerative medicine and cancer treatment by microbial transplantation in the clinic.
Palabras clave

Texto completo: 1 Bases de datos: MEDLINE Idioma: En Revista: Imeta Año: 2022 Tipo del documento: Article

Texto completo: 1 Bases de datos: MEDLINE Idioma: En Revista: Imeta Año: 2022 Tipo del documento: Article